07:00 , Apr 20, 2015 |  BC Week In Review  |  Financial News

BioAegis Therapeutics completes venture financing

BioAegis Therapeutics Corp. , Morristown, N.J.   Business: Inflammation, Infectious   Date completed: 2015-04-15   Type: Venture financing   Raised: $8 million   Investor: Not disclosed   Note: The financing is a convertible note.  ...
08:00 , Feb 18, 2013 |  BC Week In Review  |  Financial News

BioAegis Therapeutics completes venture financing

BioAegis Therapeutics Corp. , N.J.   Business: Inflammation   Date completed: 12/31/12   Type: Venture financing   Raised: $3.1 million   Investors: Not disclosed  ...
07:00 , May 30, 2011 |  BC Week In Review  |  Company News

BioAegis Therapeutics, Brigham and Women's Hospital deal

The hospital granted BioAegis an exclusive option to license worldwide rights to endogenous human protein plasma gelsolin (pGSN) for therapeutic and diagnostic uses. The option is exercisable at the close of BioAegis' series A financing....